|Articles|October 12, 2020
Size Exclusion Chromatography Method Development of NIST mAb Using an Agilent AdvanceBio SEC 200 Å 1.9 μm Column
Author(s)Agilent Technologies
Learn how to perform method optimization using a bio-inert quaternary LC instrument to screen multiple mobile phase compositions for aggregate analysis of NIST mAb.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Formulation Strategies, Tech Advances, Challenges, and Considerations in Novel Drug Delivery
2
FAQ: What You Need to Know About How Industry is Tackling CGT Bottlenecks
3
Drug Digest: Biopharma Landscape Evolves Through Strategic Alliances and Technology Integration
4
BioPharm Weekly News Roundup—Week of Nov. 24, 2025
5
